Name: IQVIA COVID-19 April briefing: A deep dive on impacts for UK&I pharma + biotech
Start: 2020-04-23T11:30:00Z
End: 2020-04-23T11:31:07.000Z
Location: BrightTALK
Rating: 4.71

pharmaphorum provides a digital podium for communicating thought leadership and innovation within pharma. Our webinars bring together different stakeholders from across the healthcare spectrum to drive fresh thinking and novel solutions that deliver better outcomes for patients.

A panel of industry experts will discuss how the NCVR is transforming study set-up timelines in the UK.

Revolutionising research: Inside the NCVR evolution in the UK

Bringing together industry panellists to share insights and lessons learned from their own professional lives on successful transformation with AI and omnichannel, and the hurdles that can occur along the way.

Harnessing Omnichannel, AI, and beyond: Reimagining Scientific Publications

To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to methods for incorporating patient voice in the development of new therapeutics, specifically as part of clinical trials.

Voices to Trials: Engaging Patients in Clinical Trial Design

Viewers will leave with the knowledge and tools needed to create an effective omnichannel content strategy that drives engagement with HCPs and helps achieve marketing goals.

How to cultivate a successful omnichannel strategy

What does it take to establish new treatments for rare diseases?

Trials and tribulations of drug development

Right research, right place, right time - this session focuses on how to place your study more strategically to optimise study performance.

An inside guide to unlocking clinical research in the UK – PART 2

Set your research on the right path - this session focuses on how to plan for success by getting expert advice on the deliverability of your proposed protocols.

An inside guide to unlocking clinical research in the UK – PART 1

The impact of the COVID-19 pandemic has added extra pressure onto an NHS system that was already facing challenges due to limitations on resources and budgets.

Partnering with NHS in a crisis: The role for industry

Engaging digitally native healthcare professionals requires companies to challenge existing business ethos and commit to the customer experience in an increasingly digital world.

Digital natives: are pharma companies ready?

Join us to learn about the pivotal role oncology PSPs can continue to play in cancer care, and the opportunities and challenges AI-powered digital cancer support platforms present to clinicians and drug makers. How close is the vision and promise to reality, and how can you tap into these next-generation digital oncology platforms to create and deliver value for your patients and your organisation?

How can digital and AI optimise delivery of patient support programs in cancer?

In this webinar, brought to you by Complete HealthVizion, three experts on MSL training will discuss the current challenges and opportunities for MSLs, the skills they need to meet those challenges, and new strategies and technologies that can be used to impart those skills.

Meeting MSL training needs in an evolving landscape

Patient centricity is a high priority these days for pharma companies, who are discovering the value of letting patients’ needs guide the development of therapies and interventions, not only to the patients but to their own outcomes and bottom lines. 

But as with any culture change, it’s important to be able to measure the change and measure its affects – or is it?

In this webinar, brought to you by the company behind A Life in a Day, patient centricity experts will draw from their own experiences to debate questions around how and why to measure these initiatives. Is it important to measure impact and prove outcomes, or is it enough to improve the patient experience for its own sake? Is it even possible to create meaningful measurements for patient centric activities, and if so, what do those measurements look like?

Join us on Wednesday, 7th December at 1 pm BST as panelists share insights and lessons from their own professional life to explore these important questions.

This webinar will also explore: 

• What meaningful patient experiences can look like and how they can affect treatment outcomes
• How to leverage the voice of the patient in creating interventions
• What KPIs are important to measure and how best to measure them

Attendees will leave with energised and educated about patient centricity, how to achieve it, and how to benchmark those achievements.

What is the true value of a “patient centric” initiative?

In this webinar, sponsored by IQVIA, the panel will discuss how the Innovative Medicines Fund works, what the implications are for industry organisations in securing funding via this route, and how this will influence uptake of medicines recommended via a NICE technology appraisal.

IMF and the opportunity for ICSs to mobilise NICE approvals

From diagnosis to treatment and ongoing condition management, the patient journey is becoming an increasingly digitized one – a process which has been massively accelerated by the Covid pandemic and has significant implications for pharmaceutical & their patients vs. their customers. 

Join us on Monday 7th November at 12:30 GMT / 13:30 CET / 7:30 am EDT as panellists lay out how a better approach to communication can lead to improved patient ou This panel will focus on how this new paradigm is shaping both the industry’s omnichannel engagement and the patient care journey, from patient identification / engagement, through telehealth, Rx fulfilment / coverage, and into ongoing support programs and adherence.

How the Digital Patient Experience is Shaping the Future of Pharma

In this webinar, sponsored by IQVIA, speakers from The Medical Informatics Group at the University Hospital Frankfurt and the Collaboration on Rare Diseases in Medical Informatics project, Germany will discuss the potential of medical informatics in rare disease research and treatment. They will also provide insight into current problems, future challenges and new ideas across the bridge between rare diseases and medical informatics.

Medical Informatics and Rare Disease: a bridge between two worlds

Join us on Tuesday 26th April for a webinar, bought to you in association with IQVIA, where key industry figures from IQVIA and Boehringer Ingelheim, along with Integrated Care System Strategy experts, will be discussing the future of the Health and Care Bill and the importance of collaborations between ICS leaders to address system readiness to improve population health.

ICSs - an opportunity to improve Patient & Market Access at a local level

In today’s competitive global market, pharmaceutical companies cannot afford to waste time or resources on strategies that do not fit patient needs or generate scripts. Interconnectivity between all stakeholders and a 360° view of everything that touches the patient are essential when mapping each patient’s and HCP’s unique and differentiated journey. But how do you ensure you are making the right connections and ensuring all key stakeholders have access to tailored education around treatments?  

In this webinar, brought to you by EVERSANA™, digital communication and design experts will dive into the history of digital communication in healthcare — and how digital channels are changing how pharma interacts with stakeholders

Is your digital communication strategy up to par?

Although resources exist for digital health entrepreneurs looking to raise their first key investment round, industry advice on next steps is harder to find. The growth of a start-up after obtaining Series A funding is a transformational phase when scaling up the company becomes critical. The CEO can experience pressure to deliver on the revenue growth goals, whilst still developing their product, growing the team, and implementing core processes for the company. 

In this webinar, we will discuss the challenges CEOs face and their personal journey during this exciting stage of entrepreneurship. Panel discussions will be based around the recent publication The Digital Health Start-up Journey: From Series A to scaling up.

The Digital Health Start-up Journey: Series A to scale-up

Overview

This April webinar is part of IQVIA’s monthly updates on the impact of COVID-19 and its implications for the healthcare ecosystem. 

In the global effort to proactively fight COVID-19, the webinar series has been designed to:
•Provide some areas which pharma and biotech companies may wish to consider around the COVID-19 outbreak, in order to help guide our community through uncertain times
•Share key healthcare impact learnings from those countries that are ahead in the COVID-19 curve
•Look at how we can, together, best support patients, healthcare professionals, life sciences and governments to reduce the impact of the virus

This April webinar will take place on Thursday 23rd April from 12.30 to 13.30 (BST) / 07:30 to 08:30 (EST).

You can listen to our March webinar here: https://pharmaphorum.com/r-d/the-potential-impact-of-coronavirus-covid-19-for-global-pharma-and-biotech-continuity/

Focus

During the April instalment, our expert panel will discuss:
•Assessing the pharmaceutical market impact of COVID-19
•The UK clinical trials on COVID-19: navigating uncharted waters  
•Genomics: research in the time of COVID-19
•Knowledge sharing: the COVID-19 experience from a US perspective  
•Getting clinical research back up and running post-coronavirus
•Adjustments to new medicine launch planning

IQVIA COVID-19 April briefing: A deep dive on impacts for UK&I pharma + biotech

Covid-19

Coronavirus

IQVIA

UK clinical trials

genomics research

pharmaceutical market impact

COVID-19 experience: US perspective

medicine launch planning

clinical research post-coronavirus

Genomics England

Get powerful marketing insights for your business. Connect with experts and colleagues to get the most up-to-date knowledge on which marketing strategies and techniques are driving customer and revenue growth.

Marketing

The marketing community on BrightTALK is made up of thousands of engaged marketing professionals. Find relevant webinars and videos on marketing strategy, branding and more presented by recognized thought leaders. Join the conversation by participating in live webinars and round table discussions.

The medical research community on BrightTALK brings together medical and research professionals. Find relevant webinars on medical research, laboratory science, continuing medical education and more presented by recognized medical researchers. Join the conversation by participating in live webinars and round table discussions on the latest in medical devices, medical research practices and trends in the healthcare industry.

Medical Research

Get powerful life science insights from influential experts. Connect with thought leaders and colleagues to get the most up-to-date knowledge on strategies and initiatives to accelerate the transformation of U.S. and global health care from a volume- to value-based marketplace.

IQVIA COVID-19 April briefing: A deep dive on impacts for UK&I pharma + biotech

Presented by

About this talk

More from this channel